EW

EW

USD

Edwards Lifesciences Corporation Common Stock

$84.150+1.100 (1.325%)

السعر في الوقت الحقيقي

Healthcare
الأجهزة الطبية
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$83.050

الأعلى

$84.830

الأدنى

$82.890

الحجم

2.64M

أساسيات الشركة

القيمة السوقية

49.4B

الصناعة

الأجهزة الطبية

البلد

United States

إحصاءات التداول

متوسط الحجم

4.58M

البورصة

NYQ

العملة

USD

نطاق 52 أسبوعاً

الأدنى $64.89الحالي $84.150الأعلى $87.09

أخبار ذات صلة

Analyst Upgrades

Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences with a Hold and raises the price target from $87 to $90.

عرض المزيد
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
Analyst Upgrades

Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99

Barclays analyst Matt Miksic maintains Edwards Lifesciences with a Overweight and raises the price target from $95 to $99.

عرض المزيد
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99
Analyst Upgrades

Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96

Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences with a Buy and raises the price target from $95 to $96.

عرض المزيد
Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96
Analyst Upgrades

JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences with a Neutral and raises the price target from $85 to $90.

عرض المزيد
JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90
Analyst Upgrades

Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104

Goldman Sachs analyst David Roman maintains Edwards Lifesciences with a Buy and raises the price target from $94 to $104.

عرض المزيد
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
Analyst Upgrades

Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95

Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences with a Overweight and raises the price target from $90 to $95.

Analyst Upgrades

RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences with a Outperform and raises the price target from $89 to $95.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.